HUDU

The Lung Circulation


€ 108,49
 
pdf eBook
Sofort lieferbar (Download)
Oktober 2013

Beschreibung

Beschreibung

The Lung Circulation, Volume 2: Pathologic Physiology and Therapy of Diseases considers the reactions of various cardiovascular and bronchopulmonary drugs for certain lung-related diseases. This book is organized into three sections encompassing 15 chapters that also cover the etiology of acute cardiopulmonary diseases and chronic pulmonary hypertension.
The first section reviews the benefits of five pulmonary treatment options, including musculotropic vasodilators and vasoconstrictors; general anesthetics and adjuvants; antitussives, expectorants, and antiallergens; Digitalis, glycosides, and quinidine; and medical and surgical procedures. The second section describes the pathologic physiology and pathogenesis of some acute cardiopulmonary diseases, such as acute injuries, systemic shock, acute pulmonary edema, pulmonary embolism, and other localized pulmonary diseases. The third section surveys numerous studies on the chronic pulmonary hypertension.
This book is directed toward pulmonologists.

Inhaltsverzeichnis

1;Front Cover;1 2;Pathologic Physiology and Therapy of Diseases;4 3;Copyright Page;5 4;Table of Contents;8 5;Dedication;6 6;LIST OF CHAPTERS;10 7;LIST OF TABLES;13 8;LIST OF FIGURES;16 9;SECTION C: Cardiovascular and Bronchopulmonary Drugs;22 9.1;CHAPTER 11. MUSCULOTROPIC VASODILATORS AND VASOCONSTRICTORS;24 9.1.1;A. XANTHINES;25 9.1.2;B. NITRITES AND NITRATES;48 9.1.3;C. MISCELLANEOUS VASODILATORS;52 9.1.4;D. MUSCULOTROPIC VASOCONSTRICTORS;56 9.1.5;REFERENCES;59 9.2;CHAPTER 12. DRUGS WITH PREDOMINANTLY CARDIAC ACTION;69 9.2.1;A. DIGITALIS GLYCOSIDES;70 9.2.2;B. ANTIFIBRILLATORY DRUGS;90 9.2.3;REFERENCES;93 9.3;CHAPTER 13. GENERAL ANESTHETICS AND ADJUVANTS;101 9.3.1;A. INHALATION ANESTHETICS;102 9.3.2;B. BARBITURATES;108 9.3.3;C. OPIATES, ANALEPTICS AND LOCAL ANESTHETICS;113 9.3.4;D. NEUROMUSCULAR BLOCKING DRUGS;121 9.3.5;E. SIGNIFICANCE OF DRUGS ACTING ON THE VOLUNTARY NERVOUS SYSTEM;126 9.3.6;REFERENCES;127 9.4;CHAPTER 14. DRUGS FOR THE RELIEF OF COUGH AND PULMONARY ALLERGIC REACTION;138 9.4.1;A. THE COUGH REFLEX;139 9.4.2;B. ANTITUSSIVE DRUGS;144 9.4.3;C. EXPECTORANTS AND AEROSOLS;152 9.4.4;REFERENCES;160 9.5;CHAPTER 15. GENERAL PRINCIPLES IN THE THERAPY OF DISEASES OF THE PULMONARY CIRCULATION: MEDICAL AND SURGICAL PROCEDURES;171 9.5.1;A. IMPROVEMENT OF CIRCULATION;172 9.5.2;B. IMPROVEMENT OF VENTILATION;179 9.5.3;C. PNEUMONECTOMY;185 9.5.4;D. SPECIAL SURGICAL PROCEDURES;191 9.5.5;REFERENCES;196 10;SECTION D: Acute Cardiopulmonary Diseases;212 10.1;CHAPTER 16. ACUTE INJURIES TO THE LUNG;214 10.1.1;A. THERMAL INJURY;215 10.1.2;B. INHALATION OF CHEMICAL FUMES;236 10.1.3;C. MISCELLANEOUS INJURIES;243 10.1.4;D. SUMMARY OF PATHOLOGICAL PHYSIOLOGY OF LUNG INJURIES;249 10.1.5;REFERENCES;250 10.2;CHAPTER 17. SYSTEMIC SHOCK OF CARDIOPULMONARY ORIGIN;259 10.2.1;A. PATHOGENESIS OF CARDIOGENIC SHOCK;260 10.2.2;B. THERAPY OF GARDIOGENIC SHOCK;264 10.2.3;C. MISCELLANEOUS FORMS OF SHOCK;282 10.2.4;D. SUMMARY OF MECHANISMS RELATED TO SYSTEMIC SHOCK;287 10.2.5;REFERENCES;288 10.
3;CHAPTER 18. ACUTE PULMONARY EDEMA;296 10.3.1;A. PATHOGENESIS OF ACUTE PULMONARY EDEMA;297 10.3.2;B. CHEMISTRY OF EDEMATOUS LUNG;321 10.3.3;C. THERAPY OF PULMONARY EDEMA;330 10.3.4;D. NERVOUS AND HUMORAL MECHANISMS RELATED TO PULMONARY EDEMA ;344 10.3.5;REFERENCES;346 10.4;CHAPTER 19. PULMONARY EMBOLISM;364 10.4.1;A. PATHOLOGICAL LESIONS;365 10.4.2;B. FUNCTIONAL CONSEQUENCES OF EMBOLIZATION;369 10.4.3;C. THERAPY OF PULMONARY EMBOLISM;380 10.4.4;REFERENCES;385 10.5;CHAPTER 20. LOCALIZED PULMONARY DISEASES;397 10.5.1;A. ATELECTASIS;398 10.5.2;B. PNEUMONIA AND TUBERCULOSIS;408 10.5.3;C. PULMONARY NEOPLASM;414 10.5.4;REFERENCES;416 11;SECTION E: Chronic Pulmonary Hypertension;426 11.1;CHAPTER 21. PATHOGENESIS OF PULMONARY HYPERTENSION; BRONCHIAL ASTHMA AND BRONCHIECTASIS;428 11.1.1;A. PATHOGENESIS OF PULMONARY HYPERTENSION;429 11.1.2;B. BRONCHIAL ASTHMA;434 11.1.3;C. BRONCHIECTASIS;440 11.1.4;REFERENCES;444 11.2;CHAPTER 22. CONGENITAL CARDIOPULMONARY ANOMALIES;451 11.2.1;A. PULMONIC STENOSIS;452 11.2.2;B. VENTRICULAR AND ATRIAL SEPTAL DEFECTS;457 11.2.3;C. PATENT DUCTUS ARTERIOSUS AND ANOMALIES OF MAJOR VESSELS ;471 11.2.4;D. FETAL CIRCULATION AND ARTIFICIAL SHUNTS;477 11.2.5;REFERENCES;483 11.3;CHAPTER 23. MITRAL STENOSIS AND LEFT VENTRICULAR FAILURE;495 11.3.1;A. MITRAL STENOSIS;496 11.3.2;B. LEFT VENTRICULAR FAILURE;523 11.3.3;C. OTHER DISEASES OF THE HEART;536 11.3.4;REFERENCES;542 11.4;CHAPTER 24. PULMONARY EMPHYSEMA AND COR PULMONALE;562 11.4.1;A. PULMONARY EMPHYSEMA;563 11.4.2;B. PNEUMOCONIOSIS AND FIBROSIS;573 11.4.3;C. CHRONIC COR PULMONALE;575 11.4.4;REFERENCES;586 11.5;CHAPTER 25. PRIMARY PULMONARY HYPERTENSION AND VASCULAR DISEASES;602 11.5.1;A. PRIMARY PULMONARY HYPERTENSION;602 11.5.2;B. PULMONARY SCHISTOSOMIASIS AND OTHER VASCULAR DISEASES;608 11.5.3;C. EXPERIMENTAL PULMONARY HYPERTENSION;612 11.5.4;REFERENCES;621 12;CONCLUDING REMARKS SPECIAL FEATURES OF THE LUNG CIRCULATION;631 13;APPENDIX: CARDIOPULMONARY REFLEXES;638 14;POSTSCRIPT: PUBLICATION EXPLOS
ION;650 15;AUTHOR INDEX;656 16;SUBJECT INDEX;766


EAN: 9781483223063
Untertitel: Pathologic Physiology and Therapy of Diseases. 200:Adobe eBook. Sprache: Englisch.
Verlag: Elsevier Science
Erscheinungsdatum: Oktober 2013
Format: pdf eBook
Kopierschutz: Adobe DRM
Es gibt zu diesem Artikel noch keine Bewertungen.Kundenbewertung schreiben